You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tedizolid

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

Gram-Positive Infections Trial in Worldwide (IV Tedizolid Phosphate, Oral Suspension Tedizolid Phosphate)

Recruiting
  • Gram-Positive Infections
  • IV Tedizolid Phosphate
  • Oral Suspension Tedizolid Phosphate
  • Little Rock, Arkansas
  • +27 more
Aug 18, 2022

Reference Center

Completed
  • Bone and Joint Infection
  • patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
  • Lyon, France
    Hospices Civils de Lyon
Jun 15, 2021

Prosthetic Joint Infection Trial in Boulogne-Billancourt, Lyon (Tedizolid Phosphate 200 MG [Sivextro])

Completed
  • Prosthetic Joint Infection
  • Tedizolid Phosphate 200 MG [Sivextro]
  • Boulogne-Billancourt, France
  • +1 more
Sep 6, 2021

Endocarditis Infective Trial in Barcelona (Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection)

Not yet recruiting
  • Endocarditis Infective
  • Barcelona, Spain
    Hospital Clinic i Provincial de Barcelona
May 26, 2022

Bone and Joint Infection Trial in Torrance (Tedizolid)

Unknown status
  • Bone and Joint Infection
  • Tedizolid
  • Torrance, California
  • +1 more
Feb 22, 2021

Cystic Fibrosis Trial in Los Angeles (Tedizolid PO, Tedizolid IV)

Completed
Has Results
  • Cystic Fibrosis
  • Tedizolid PO
  • Tedizolid IV
  • Los Angeles, California
    University of Southern California
May 21, 2020

Prostheses Infection Trial (Sivextro 200 milligrams Oral Tablet)

Unknown status
  • Prostheses Infection
  • Sivextro 200 milligrams Oral Tablet
  • (no location specified)
Feb 4, 2020

Gram-Positive Bacterial Infections Trial (Tedizolid Phosphate (IV), Tedizolid Phosphate (oral suspension))

Completed
Has Results
  • Gram-Positive Bacterial Infections
  • Tedizolid Phosphate (IV)
  • Tedizolid Phosphate (oral suspension)
  • (no location specified)
Dec 2, 2019

Skin Diseases, Infectious, Skin Diseases, Bacterial Trial (Tedizolid Phophate, Antibiotic comparator, Aztreonam)

Completed
Has Results
  • Skin Diseases, Infectious
  • Skin Diseases, Bacterial
  • Tedizolid Phophate
  • +3 more
  • (no location specified)
Jul 12, 2019

Pneumonia Trial (Tedizolid phosphate, Linezolid)

Completed
Has Results
  • Pneumonia
  • (no location specified)
Jun 10, 2019

Sivextro in Acute Bacterial Skin and Skin Structure Infection in

Terminated
  • Skin Disease, Infectious
  • Multiple Locations, Mexico
  • +2 more
Sep 30, 2019

Diabetes, Wound Infection, Healthy Volunteers Trial in Hartford (Tedizolid, Microdialysis Catheter Insertion)

Completed
Has Results
  • Diabetes
  • +2 more
  • Tedizolid
  • Microdialysis Catheter Insertion
  • Hartford, Connecticut
    Hartford Hospital
Jul 31, 2018

Healthy Volunteer Trial in Dallas (TR-701 FA 1200 mg, Moxifloxacin 400 mg, TR-701 FA 200 mg plus Placebo)

Completed
  • Healthy Volunteer
  • TR-701 FA 1200 mg
  • +3 more
  • Dallas, Texas
    Trius Investigator
Dec 3, 2018

Sepsis, Acute Kidney Injury Trial (blood samples and filtered fluid will be collected.)

Not yet recruiting
  • Sepsis
  • Acute Kidney Injury
  • blood samples and filtered fluid will be collected.
  • (no location specified)
Mar 18, 2021

Bacterial Infections, Fungal Infection Trial in Spain (Non-impositive Program for Optimizing the Use of Antimicrobials)

Unknown status
  • Bacterial Infections
  • Fungal Infection
  • Non-impositive Program for Optimizing the Use of Antimicrobials
  • Almería, Spain
  • +13 more
May 28, 2020

Healthy Subjects Trial in Overland Park (TR-701 FA with PSE, TR-701 FA Placebo with PSE)

Completed
  • Healthy Subjects
  • TR-701 FA with PSE
  • TR-701 FA Placebo with PSE
  • Overland Park, Kansas
    Trius Investigator Site 001
Aug 19, 2018

Bacterial Infection Trial in Hartford (TR-701 FA)

Completed
  • Bacterial Infection
  • TR-701 FA
  • Hartford, Connecticut
    Trius Investigator Site 001
Nov 13, 2019

Healthy Trial in Gainesville (TR-700 (active moiety), TR-701 (pro-drug))

Completed
  • Healthy
  • TR-700 (active moiety)
  • TR-701 (pro-drug)
  • Gainesville, Florida
    General Clinical Research Center
Nov 13, 2019

Major Cutaneous Abscess, Cellulitis, Erysipelas Trial in United States (TR701 FA)

Completed
Has Results
  • Major Cutaneous Abscess
  • +2 more
  • TR701 FA
  • Anaheim, California
  • +9 more
Jul 31, 2018

Skin Diseases, Infectious, Skin Diseases, Bacterial Trial in United States (TR-701 200 mg, TR-701 300 mg, TR-701 400 mg)

Completed
Has Results
  • Skin Diseases, Infectious
  • Skin Diseases, Bacterial
  • TR-701 200 mg
  • +2 more
  • Dothan, Alabama
  • +11 more
Nov 11, 2019

Healthy Trial in Seoul (DA-7218, Placebo)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 23, 2019

Healthy Trial in Madison (Human ADME)

Completed
  • Healthy
  • Human ADME
  • Madison, Wisconsin
    Trius Investigator Site 001
Nov 13, 2019

Skin Diseases, Infectious Trial in Japan (Tedizolid Phosphate (Sivextro, BAY1192631), Linezolid)

Completed
Has Results
  • Skin Diseases, Infectious
  • Tedizolid Phosphate (Sivextro, BAY1192631)
  • Linezolid
  • Nagakute, Aichi, Japan
  • +45 more
Sep 6, 2018

Healthy Subjects Trial in Dallas (TR-701 FA)

Completed
  • Healthy Subjects
  • TR-701 FA
  • Dallas, Texas
    Trius Investigator Site 001
Oct 4, 2017